Telerehabilitation for people with Parkinson's Disease
Home Telerehabilitation Based on Serious Games for Continuity of Care in People With Parkinson's Disease
This study is testing whether a home-based telerehabilitation program using fun games can help people with Parkinson's Disease do daily activities better compared to regular hospital treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 30 Years to 80 Years |
| Sex | All |
| Sponsor | IRCCS San Raffaele Roma Academic / other |
| Locations | 2 sites (Cassino, Frosinone and 1 other locations) |
| Trial ID | NCT05773885 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a home-based telerehabilitation program using serious games for individuals with Parkinson's Disease, comparing it to traditional day-hospital treatment. The aim is to enhance patients' autonomy in daily activities by leveraging technology to provide personalized rehabilitation. The study addresses the challenges of accessing rehabilitation services, particularly for those living far from specialized centers, by utilizing telemedicine to deliver care remotely. Participants will engage in tailored rehabilitation sessions monitored in real-time to track their progress.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 30 to 80 with a diagnosis of Parkinson's Disease and a Hoehn & Yahr score of 2 to 3.
Not a fit: Patients with cognitive impairments, other neurological disorders, or those unable to comply with the telerehabilitation system may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and independence of patients with Parkinson's Disease.
How similar studies have performed: Previous studies have shown that telerehabilitation is feasible and effective for managing various aspects of Parkinson's Disease, although this specific approach is still being explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 30 and 80 years; * diagnosis of Parkinson's Disease according to the "Movement Disorders Society's diagnostic criteria"; * Hoehn \& Yahr (H\&Y) score between 2 and 3 (ON-state); * absence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 ≤ 2; * absence of cognitive impairment measured by the MoCA total score ≥ 18; * stabilized drug treatment; * have access to the Internet for TR; * have a caregiver available during rehabilitation sessions in TR; * have sufficient cognitive and linguistic level to understand and comply with study procedures; * sign informed consent. Exclusion Criteria: * having any cognitive problems or low compliance that prevent using the TR system; * other neurological pathologies, psychiatric complications or personality disorders; * musculoskeletal diseases that impair movement; * presence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 \> 2; * presence of cognitive impairment measured by the MoCA total score \< 18; * severe cognitive or linguistic deficits (inability to understand and comply with study procedures); * presence of blurred or low vision problems; * hearing and speech impairment affecting participation in the system; * absence of signature of the informed consent.
Where this trial is running
Cassino, Frosinone and 1 other locations
- San Raffaele Cassino — Cassino, Frosinone, Italy (Not_yet_recruiting)
- IRCCS San Raffaele Roma — Rome, Italy, Italy (Recruiting)
Study contacts
- Principal investigator: Dr. Sanaz Pournajaf, DPT — IRCCS San Raffaele Roma
- Study coordinator: Dr. Sanaz Pournajaf, DPT
- Email: sanaz.pournajaf@sanraffaele.it
- Phone: +39 0652252405
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.